Therapeutic areas

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

PHASE I SPECIAL POPULATIONS

phase i special populations

ARENSIA offers exceptional fast recruitment rates for renal and hepatic impaired patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

THERAPEUTIC AREAS

ARENSIA delivers outstanding recruitment rates in the following therapeutic areas: immuno-inflammatory, cardiovascular, diabetes/metabolic, respiratory, hepatology, nephrology, gastroenterology, infectious diseases HCV/HIV, urology, oncology, dermatology, neurology, psychiatry, ophthalmology, selected pediatrics.

Disease diagnostics at ARENSIA locations follows US and European guidelines. Patient files are extraordinarily well documented, which helps for accurate patient selection. Especially in immunology and oncology, the patient pools are mainly naïve of expensive biological therapies. In other indications (e.g. cardiovascular, metabolic, respiratory, neurosciences) patients are generally treated with therapies approved recently in Western countries, while having large pools of patients which are treatment naïve (e.g. treatment naïve T2D patients, or T2D patients on metformin monotherapy).

Below are examples of patient populations within key therapeutic areas at ARENSIA:

IMMUNOLOGY View information

  • Rheumatoid Arthritis
  • Inflammatory Arthritis
  • Osteoarthritis
  • Psoriasis, Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Lupus (all forms )
  • Ulcerative Colitis
  • Atopic Dermatitis
  • Asthma

ONCOLOGY View information

  • Colorectal cancer
  • Breast cancer
  • Lung cancer
  • Skin cancer
  • Hemoblastosis
  • Gastric Cancer
  • Cervical Cancer
  • Prostate Cancer
  • Liver Cancer
  • Thyroid Cancer
  • Other Cancers

CARDIOVASCULAR View information

  • Arterial Hypertension
  • Pulmonary Hypertension
  • Chronic Heart Failure (NYHA II-IV)
  • Coronary Heart Disease: Stable Angina
  • Acute Coronary Syndrome, MI
  • Arrhythmia
  • Hypertrophic Cardiomyopathy
  • Valvular Diseases
  • Peripheral Artery Diseases
  • Metabolic Syndrome

RENAL & HEPATIC FAILURE View information

  • Renal Impairment: Mild, Moderate, Severe, ESRD (with & without dialysis)
  • Hepatic Impairment: Child Pugh A, B, C

PEDIATRICS View information

Patients (age 0-18) with chronic and acute conditions, such as:

  • Respiratory
  • Immunology
  • Eye condition
  • Gastro-enterology
  • Cardiology
  • Endocrinology/metabolics
  • Neuropsychiatry
  • Genetics

INFECTIOUS DISEASES View information

  • Hepatitis C (GT1b, GT3, GT2, GT4)
  • Hepatitis B
  • HIV
  • co-infections
  • Other Infectious Diseases

METABOLICS View information

  • Type 1/ Type 2 Diabetes
  • Diabetic Nephropathy
  • Diabetic Neuropathy
  • Diabetic Retinopathy
  • Impaired Glucose Tolerance
  • Dyslipidemia
  • Obesity

RESPIRATORY View information

  • Asthma
  • COPD
  • Interstitial lung diseases Sarcoidosis
  • Acute respiratory infections

NEUROSCIENCES View information

  • Acute Psychosis, Schizophrenia, Bipolar disorders
  • Depression, Anxiety, Somatophobe Disorders
  • Dementia (Alzheimer)
  • Epilepsies
  • Psychosomatic Disorders
  • Multiple Sclerosis
  • Parkinson
  • Pain